Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Risk of Dementia Through Deprescribing (R2D2)

NCT04270474 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT04270474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04270474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Risk of Dementia Through Deprescribing (R2D2)
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Completed
Start date
July 20, 2020
Completion date
July 29, 2026
Enrollment
344 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, late onset, dementia